In fact, by regulating PD-L1 expression, IGF2BP2 may contribute to immune evasion, further promoting tumour survival in the immune-suppressive microenvironment of pancreatic cancer [158]. The gene discussed is IGF2BP2; the disease is pancreatic neoplasm.